Logo image of ARVN

ARVINAS INC (ARVN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ARVN - US04335A1051 - Common Stock

11.47 USD
-0.39 (-3.29%)
Last: 1/2/2026, 8:00:01 PM
11.47 USD
0 (0%)
Pre-Market: 1/5/2026, 8:01:33 AM
Fundamental Rating

2

Taking everything into account, ARVN scores 2 out of 10 in our fundamental rating. ARVN was compared to 191 industry peers in the Pharmaceuticals industry. While ARVN seems to be doing ok healthwise, there are quite some concerns on its profitability. ARVN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ARVN had negative earnings in the past year.
ARVN had a negative operating cash flow in the past year.
ARVN had negative earnings in each of the past 5 years.
In the past 5 years ARVN reported 4 times negative operating cash flow.
ARVN Yearly Net Income VS EBIT VS OCF VS FCFARVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.92%, ARVN is in the better half of the industry, outperforming 70.68% of the companies in the same industry.
ARVN has a better Return On Equity (-10.35%) than 73.82% of its industry peers.
Industry RankSector Rank
ROA -6.92%
ROE -10.35%
ROIC N/A
ROA(3y)-22.88%
ROA(5y)-19.47%
ROE(3y)-47.02%
ROE(5y)-36.82%
ROIC(3y)N/A
ROIC(5y)N/A
ARVN Yearly ROA, ROE, ROICARVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARVN Yearly Profit, Operating, Gross MarginsARVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

More info and screens

4

2. Health

2.1 Basic Checks

ARVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARVN has more shares outstanding
ARVN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARVN has been reduced compared to a year ago.
ARVN Yearly Shares OutstandingARVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ARVN Yearly Total Debt VS Total AssetsARVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.04, we must say that ARVN is in the distress zone and has some risk of bankruptcy.
ARVN has a Altman-Z score of -0.04. This is comparable to the rest of the industry: ARVN outperforms 45.55% of its industry peers.
ARVN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, ARVN is in the better half of the industry, outperforming 62.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.04
ROIC/WACCN/A
WACC9.34%
ARVN Yearly LT Debt VS Equity VS FCFARVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

ARVN has a Current Ratio of 5.70. This indicates that ARVN is financially healthy and has no problem in meeting its short term obligations.
ARVN's Current ratio of 5.70 is fine compared to the rest of the industry. ARVN outperforms 65.97% of its industry peers.
ARVN has a Quick Ratio of 5.70. This indicates that ARVN is financially healthy and has no problem in meeting its short term obligations.
ARVN's Quick ratio of 5.70 is fine compared to the rest of the industry. ARVN outperforms 67.02% of its industry peers.
Industry RankSector Rank
Current Ratio 5.7
Quick Ratio 5.7
ARVN Yearly Current Assets VS Current LiabilitesARVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

ARVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.66%, which is quite impressive.
Looking at the last year, ARVN shows a quite strong growth in Revenue. The Revenue has grown by 10.47% in the last year.
Measured over the past years, ARVN shows a very strong growth in Revenue. The Revenue has been growing by 43.69% on average per year.
EPS 1Y (TTM)82.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.41%
Revenue 1Y (TTM)10.47%
Revenue growth 3Y78.01%
Revenue growth 5Y43.69%
Sales Q2Q%-59.08%

3.2 Future

ARVN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.50% yearly.
ARVN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.00% yearly.
EPS Next Y72.55%
EPS Next 2Y-5.18%
EPS Next 3Y-3.18%
EPS Next 5Y7.5%
Revenue Next Year9.76%
Revenue Next 2Y-40.1%
Revenue Next 3Y-29.39%
Revenue Next 5Y-4%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARVN Yearly Revenue VS EstimatesARVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ARVN Yearly EPS VS EstimatesARVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15 -20 -25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ARVN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARVN Price Earnings VS Forward Price EarningsARVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARVN Per share dataARVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as ARVN's earnings are expected to decrease with -3.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.18%
EPS Next 3Y-3.18%

More info and screens

0

5. Dividend

5.1 Amount

ARVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ARVINAS INC

NASDAQ:ARVN (1/2/2026, 8:00:01 PM)

Premarket: 11.47 0 (0%)

11.47

-0.39 (-3.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-09 2026-02-09/amc
Inst Owners96.53%
Inst Owner Change0%
Ins Owners2.5%
Ins Owner Change0.36%
Market Cap736.60M
Revenue(TTM)312.30M
Net Income(TTM)-58.40M
Analysts74.62
Price Target13.2 (15.08%)
Short Float %11.41%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.38%
Min EPS beat(2)18.03%
Max EPS beat(2)40.73%
EPS beat(4)4
Avg EPS beat(4)79.1%
Min EPS beat(4)18.03%
Max EPS beat(4)218.09%
EPS beat(8)7
Avg EPS beat(8)41.08%
EPS beat(12)9
Avg EPS beat(12)29.09%
EPS beat(16)9
Avg EPS beat(16)16.23%
Revenue beat(2)1
Avg Revenue beat(2)23.18%
Min Revenue beat(2)-27.7%
Max Revenue beat(2)74.06%
Revenue beat(4)2
Avg Revenue beat(4)95.07%
Min Revenue beat(4)-27.7%
Max Revenue beat(4)345.02%
Revenue beat(8)4
Avg Revenue beat(8)34.48%
Revenue beat(12)7
Avg Revenue beat(12)34.53%
Revenue beat(16)10
Avg Revenue beat(16)34.32%
PT rev (1m)0.92%
PT rev (3m)7.84%
EPS NQ rev (1m)3.06%
EPS NQ rev (3m)13.46%
EPS NY rev (1m)5.39%
EPS NY rev (3m)37.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.72%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)10.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.36
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB 1.31
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-3.06
Fwd EYN/A
FCF(TTM)-5.13
FCFYN/A
OCF(TTM)-5.1
OCFYN/A
SpS4.86
BVpS8.79
TBVpS8.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.92%
ROE -10.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.88%
ROA(5y)-19.47%
ROE(3y)-47.02%
ROE(5y)-36.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.82%
Cap/Sales 0.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.7
Quick Ratio 5.7
Altman-Z -0.04
F-Score6
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)69.16%
Cap/Depr(5y)101.08%
Cap/Sales(3y)3.18%
Cap/Sales(5y)9.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.41%
EPS Next Y72.55%
EPS Next 2Y-5.18%
EPS Next 3Y-3.18%
EPS Next 5Y7.5%
Revenue 1Y (TTM)10.47%
Revenue growth 3Y78.01%
Revenue growth 5Y43.69%
Sales Q2Q%-59.08%
Revenue Next Year9.76%
Revenue Next 2Y-40.1%
Revenue Next 3Y-29.39%
Revenue Next 5Y-4%
EBIT growth 1Y82.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year69.25%
EBIT Next 3Y8.93%
EBIT Next 5YN/A
FCF growth 1Y3.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.53%
OCF growth 3YN/A
OCF growth 5YN/A

ARVINAS INC / ARVN FAQ

What is the ChartMill fundamental rating of ARVINAS INC (ARVN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ARVN.


Can you provide the valuation status for ARVINAS INC?

ChartMill assigns a valuation rating of 0 / 10 to ARVINAS INC (ARVN). This can be considered as Overvalued.


Can you provide the profitability details for ARVINAS INC?

ARVINAS INC (ARVN) has a profitability rating of 1 / 10.


What is the expected EPS growth for ARVINAS INC (ARVN) stock?

The Earnings per Share (EPS) of ARVINAS INC (ARVN) is expected to grow by 72.55% in the next year.